Suppr超能文献

20 年血管重建相关经验,在单一癌症中心行恶性肿瘤切除术。

Twenty years of experience in vascular reconstructions associated with resection of malignant neoplasms in a single cancer center.

机构信息

AC Camargo Cancer Center, São Paulo, Brazil.

AC Camargo Cancer Center, São Paulo, Brazil.

出版信息

J Vasc Surg. 2019 Jun;69(6):1880-1888. doi: 10.1016/j.jvs.2018.08.196. Epub 2018 Dec 24.

Abstract

OBJECTIVE

Vascular invasion is no longer considered to be an absolute contraindication to tumor removal, and complex reconstructions are part of the daily activity of vascular surgeons in specialized cancer centers. Our aim was to report a single-center experience of complex vascular reconstructions involving en bloc resection of tumors and patients' long-term survival and graft patency outcomes. To the best of our knowledge, this is the largest report of vascular reconstructions published to date, with the longest follow-up.

METHODS

Between September 1997 and January 2016, there were 91 patients who underwent 92 arterial and 47 venous reconstruction procedures in this retrospective cohort study. Long-term survival and patency outcomes were analyzed for all study patients and individually assessed in different body segments (head and neck, thorax, upper limbs, abdomen, and lower limbs).

RESULTS

The estimated mean and median follow-up times were 112.66 and 100 months, respectively. The 24- and 60-month survival estimates for the patients overall were 55.3% and 31.1%, respectively. Survival estimates were significantly lower in the head and neck cases compared with the other body segments. The primary arterial patency rates at 24 and 60 months were 96.7% and 84.9%, respectively, and they were similar in all body segments. The venous patency rates were 71.4% and 64.2% at 24 and 60 months, respectively. Seven cases (7.6%) of arterial vascular complications were observed.

CONCLUSIONS

Vascular reconstruction performed in conjunction with oncologic resection is a feasible treatment option for tumors with vessel involvement. When surgery is performed in specialized centers, low perioperative morbidity and long-term patency rates are expected irrespective of the vascular territory undergoing intervention.

摘要

目的

血管侵犯不再被视为肿瘤切除的绝对禁忌,复杂的重建是专门癌症中心血管外科医生日常活动的一部分。我们的目的是报告一个涉及肿瘤整块切除和患者长期生存及移植物通畅率结果的单中心经验。据我们所知,这是迄今为止发表的最大规模的血管重建报告,随访时间最长。

方法

在这项回顾性队列研究中,1997 年 9 月至 2016 年 1 月期间,有 91 例患者接受了 92 次动脉和 47 次静脉重建手术。对所有研究患者进行了长期生存和通畅率结果分析,并分别在不同的身体部位(头颈部、胸部、上肢、腹部和下肢)进行评估。

结果

估计的平均和中位随访时间分别为 112.66 和 100 个月。总体患者的 24 个月和 60 个月生存率估计分别为 55.3%和 31.1%。与其他身体部位相比,头颈部病例的生存率明显较低。24 个月和 60 个月时的主要动脉通畅率分别为 96.7%和 84.9%,在所有身体部位均相似。静脉通畅率分别为 71.4%和 64.2%,在 24 个月和 60 个月时。观察到 7 例(7.6%)动脉血管并发症。

结论

在肿瘤切除时进行血管重建是血管受累肿瘤的一种可行治疗选择。当在专门的中心进行手术时,无论介入的血管区域如何,都有望获得低围手术期发病率和长期通畅率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验